Oklahoma Arthritis Network

Oklahoma Arthritis Center (OAC) is a premier integrated healthcare provider and clinical research center specializing in rheumatology and autoimmune diseases. Founded in 2000 by Dr. Craig W. Carson and headquartered in Edmond, Oklahoma, the center provides a comprehensive care model that includes advanced diagnostics, infusion therapy, and specialized treatment for conditions such as rheumatoid arthritis, lupus, and ankylosing spondylitis. OAC is a significant participant in the global clinical research landscape, serving as a site for Phase 1 through Phase 4 clinical trials in partnership with major pharmaceutical companies like GSK, Pfizer, and Eli Lilly. The organization is also known for its adoption of innovative healthcare technologies, such as AI-driven patient engagement platforms, to enhance operational efficiency and patient outcomes. OAC operates a network of clinics across Oklahoma, including locations in Norman, Elk City, and Stillwater, and is often associated with the broader Oklahoma Arthritis Network of care providers.